ライブ

FierceBiotechAntibodies that stop measles from stabbing cells could become new treatments for the surging virus, study suggests FierceBiotechBeOne shelves 5 cancer programs, halts phase 2 rheumatoid arthritis trial Endpoints NewsEntrada stock falls on Duchenne data; Wegovy expands access CellVirological characteristics of SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia CellAffinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections CellMulti-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome FierceBiotechBlackstone invests $250M in Anagram to reduce burden of cystic fibrosis complication FierceBiotechFDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?BioWorldFirst measles treatment advances as vaccination rates drop FierceBiotechAscendis axes IL-2 program in retreat from oncology expansion PharmaVoiceNovo hikes guidance on Wegovy pill’s fast sales start Endpoints NewsAmgen adds $300M to Puerto Rico budget; Novartis to exit oral drug factory in Germany

Endpoints News 2026年5月7日

Pennsylvania sues AI chatbot company for posing as a licensed doctor

The state of Pennsylvania has sued Character.AI, a startup that lets users chat with different AI-generated personas, for illegally presenting a chatbot as a li...

The state of Pennsylvania has sued Character.AI, a startup that lets users chat with different AI-generated personas, for illegally presenting a chatbot as a licensed doctor in the state. This is the first lawsuit brought ...